Systemic administration of beta-glucan induces immune training in microglia by Heng, Yang et al.






The following full text is a publisher's version.
 
 





Please be advised that this information was generated on 2021-11-02 and may be subject to
change.
RESEARCH Open Access
Systemic administration of β-glucan
induces immune training in microglia
Yang Heng1†, Xiaoming Zhang1†, Malte Borggrewe1, Hilmar R. J. van Weering1, Maaike L. Brummer1,
Tjalling W. Nijboer1, Leo A. B. Joosten2, Mihai G. Netea2,3, Erik W. G. M. Boddeke1,4, Jon D. Laman1 and
Bart J. L. Eggen1*
Abstract
Background: An innate immune memory response can manifest in two ways: immune training and immune
tolerance, which refers to an enhanced or suppressed immune response to a second challenge, respectively.
Exposing monocytes to moderate-to-high amounts of bacterial lipopolysaccharide (LPS) induces immune tolerance,
whereas fungal β-glucan (BG) induces immune training. In microglia, it has been shown that different LPS inocula
in vivo can induce either immune training or tolerance. Few studies focused on impact of BG on microglia and
were only performed in vitro. The aim of the current study was to determine whether BG activates and induces
immune memory in microglia upon peripheral administration in vivo.
Methods: Two experimental designs were used. In the acute design, mice received an intraperitoneal (i.p.) injection
with PBS, 1 mg/kg LPS or 20 mg/kg BG and were terminated after 3 h, 1 or 2 days. In the preconditioning design,
animals were first challenged i.p. with PBS, 1 mg/kg LPS or 20 mg/kg BG. After 2, 7 or 14 days, mice received a
second injection with PBS or 1 mg/kg LPS and were sacrificed 3 h later. Microglia were isolated by fluorescence-
activated cell sorting, and cytokine gene expression levels were determined. In addition, a self-developed program
was used to analyze microglia morphological changes. Cytokine concentrations in serum were determined by a
cytokine array.
Results: Microglia exhibited a classical inflammatory response to LPS, showing significant upregulation of Tnf, Il6,
Il1β, Ccl2, Ccl3 and Csf1 expression, three h after injection, and obvious morphological changes 1 and 2 days after
injection. With an interval of 2 days between two challenges, both BG and LPS induced immune training in
microglia. The training effect of LPS changed into immune tolerance after a 7-day interval between 2 LPS
challenges. Preconditioning with BG and LPS resulted in increased morphological changes in microglia in response
to a systemic LPS challenge compared to naïve microglia.
Conclusions: Our results demonstrate that preconditioning with BG and LPS both induced immune training of
microglia at two days after the first challenge. However, with an interval of 7 days between the first and second
challenge, LPS-preconditioning resulted in immune tolerance in microglia.
Keywords: microglia, innate immune memory, training, tolerance, β-glucan, lipopolysaccharide, morphology,
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Background
In recent years, it has become evident that in partial ana-
logy to adaptive immune cells, innate immune cells, like
monocytes and macrophages, also can acquire immune
memory. This immunological memory has been referred
to as innate immune memory [1, 2]. Innate immune
memory can manifest in two different ways, immune
training and immune tolerance, which means an en-
hanced or suppressed immune response towards a sec-
ondary challenge. In monocytes, immune training and
tolerance are two distinct functional fates induced by
specific microbial ligands and underpinned by epigenetic
reprogramming [3–5].
Lipopolysaccharide (LPS) and β-glucan (BG) are two
commonly used ligands to induce immune tolerance and
training in monocytes/macrophages, respectively. LPS is
a cell wall component of Gram-negative bacteria and a
potent trigger of inflammatory responses in monocytes/
macrophages by activating Toll-like receptor (TLR) 4
[6]. After the first LPS challenge, animals or cultured
monocytes/macrophages become refractory to a second
challenge of LPS or other inflammatory stimuli, a
phenomenon called LPS tolerance [7]. In monocytes/
macrophages, LPS tolerance requires hypoxia-inducible
factor-1α (HIF1α) [8], and is mediated by epigenetic
modifications through transcription factors RelB and
ATF7 [9–11]. LPS tolerance resembles the immune par-
alysis observed in sepsis patients or other non-infectious
systemic inflammatory response syndrome [12–14]. The
first LPS challenge can reduce a second LPS-induced fe-
brile response, metabolic changes and lethality from ex-
perimental models of septic shock [7]. In addition, LPS
preconditioning was shown to be protective against sub-
sequent cerebral ischemic injury by the induction of
neuroprotective spleen monocytes, which mobilize to
the brain and meninges, suppressing post-ischemic in-
flammation [15, 16]. Thus, LPS tolerance in general is
viewed as a protective adaption to a second challenge.
Nevertheless, LPS preconditioning also sometimes in-
duces detrimental effects. Mice preconditioned with a
super-low dose (5 ng/kg body weight) of LPS displayed
exacerbated sepsis-induced tissue damage, bacterial load
in circulation, and mortality [17].
BG is the most abundant fungal cell wall polysacchar-
ide and a promising biological response modifier for the
treatment of cancer and infectious diseases [18, 19]. BGs
share a common structure consisting of a backbone of
β-(1,3)-linked glucose residues, but their length and
branching structure vary considerably. BGs isolated from
different sources with different structural complexity
have different immunomodulatory properties [20, 21].
BG preconditioning can induce immune training in hu-
man and mouse monocytes in vitro and protects mice
against an otherwise lethal infection with C. albicans
[22]. The in vitro training is characterized by epigenetic
programming and a metabolic shift to aerobic glycolysis,
which requires the BG receptor Dectin-1 (CLEC7A), the
non-canonical Raf-1 pathway and Akt-mTOR-HIF-1α
pathways [3, 22, 23]. BG also induces immune training
in the periphery in vivo, indicated by enhanced serum
cytokine concentrations in response to a secondary LPS
stimulation [24].
Microglia, the innate immune cells of the central ner-
vous system (CNS), can adopt diverse phenotypes and
functions in health and disease [25]. The capacity of
microglia to develop innate immune memory has re-
cently been demonstrated [26]. In our previous study,
we have shown that LPS preconditioning induces im-
mune tolerance in microglia, characterized by sup-
pressed Tnf, Il1b and Il6 gene expression in response to
a second LPS challenge. This phenomenon was observed
in a microglial cell line, in primary microglia, and in vivo
[27]. For in vivo experiments, we showed that a single
intraperitoneal (i.p.) injection of LPS induced immune
tolerance in microglia for 1, 4 and even 32 weeks after
injection [27]. Wendeln et al. used a different LPS chal-
lenge paradigm, and showed that a single LPS injection
induced immune training whereas four consecutive daily
intraperitoneal (i.p.) LPS injections induced microglia
tolerance in mice [28]. Studies on how different LPS
treatment schedules and inocula induce different types
of microglia immune memory were extensively reviewed
by Neher and Cunningham [26].
Compared to LPS, relatively little is known about the
effects of BG on microglia. In primary microglia in vitro,
BG induces phagocytosis and radical oxygen species
(ROS) production via the Dectin-1 without inducing sig-
nificant cytokine production [29, 30]. Co-stimulation of
primary microglia with BG suppresses TLR2- (by
Pam3Csk4) and TLR4-mediated (by LPS) activation of
nuclear factor-κB (NF-κB) [31]. Moreover, in BV-2 cells,
pre-treatment with BG reduces LPS-induced Tnf expres-
sion and NF-κB activation [32]. However, to date, no
studies have studied whether BG activates microglia and
induces immune memory in vivo. In this study, we re-
port for the first time that systemic administration of
BG activates microglia in vivo, and that BG precondi-
tioning induces immune training in microglia.
Methods
BV-2 cell culture and luciferase assays
BV-2 cells were cultured in Dulbecco’s Modified Eagle
Medium (DMEM, Lonza, BE12-707F) supplemented
with 10% FCS (Bovogen Biologicals, Keilor East,
Australia) and 1% pen/strep (GE Healthcare, Little Chal-
font, UK) at 37°C in a humidified atmosphere at 5%
CO2. For luciferase assays, BV-2 cells with a luciferase
reporter gene driven by consensus NF-κB binding sites
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were used. The high sensitivity luminescence reporter
gene assay system kit (Steadylite plus, PerkinElmer) was
used to measure the luciferase activity and the signal
was recorded in a Luminometer. The BV-2 NF-κB lucif-
erase reporter cell line was generated by transduction of
BV-2 cells with lentiviral Cignal™ Lenti Reporters (Luc)
following the manufacturer's protocol (Qiagen, CLS-
013L). Afterwards, the transduced BV-2 cells were
seeded in 6 well plates with 4 mg/mL puromycin in the
culture medium. The single colonies were selected and
expanded. The activation of NF-κB by LPS was analyzed
as previously described [33, 34].
Primary microglia culture
Primary neonatal microglia were isolated from brains of
postnatal day 0-2 C57Bl/6J mouse pups as described
previously [27]. Briefly, the brains were minced after re-
moving the cerebellum and meninges, followed by 25-35
min 0.25% trypsin dissociation. The tissue was then trit-
urated using glass pipettes. Cells were centrifuged and
resuspended in microglia medium incubated at 37°C
with 5% CO2. The microglia medium is DMEM supple-
mented with 10% FCS (Gibco, 10500-064), 1 mM so-
dium pyruvate (Gibco, 11360-070) and 1% penicillin/
streptomycin (GE Healthcare, P11-010). When conflu-
ent, the medium was refreshed by 10 mL microglia
medium and 5 mL LCCM (L929 cell line conditioned
medium, DMEM with 10% FCS and 1% penicillin/
streptomycin). Three to four days later, microglia were
collected by orbital shaking at 37°C and 150 rpm/min
for 1 h. Afterwards, the microglia-enriched cell suspen-
sion was centrifuged. The supernatant was filtered (20
μm filter) and used as conditioned medium. The micro-
glia were seeded and cultured in the microglia culture
medium (fresh microglia medium containing 50% condi-
tioned medium collected after shake off). For stimula-
tion, one day after microglia were seeded, the medium
was refreshed with microglia culture medium containing
PBS, LPS (100 ng/mL) or β-glucan (10 μg/mL). At 3 h
after the stimulation, cells were washed with PBS and
total RNA was isolated using TRIzol™ Reagent (Thermo
Fisher Scientific, 15596026).
Animals
All the animal work was performed in the Central Ani-
mal Facility (CDP) approved by Animal Care and Use
Committee (DEC) of the University of Groningen with
protocol (IvD 15360-03-002). C57Bl/6J mice (male, 8-10
weeks, 25-30 grams) were purchased from Envigo (Har-
lan, the Netherlands). Mice were individually housed
under a 12/12 h light/dark cycle (8 p.m. lights off, 8 a.m.
lights on) with ad libitum access to food and water. Two
experimental designs were used (acute and precondition-
ing). For the acute design, animals were challenged once
via i.p. injection with LPS (Sigma-Aldrich, E. coli, O111:
B4, L4391, 1 mg/kg body weight) or BG (Sigma-Aldrich,
S. cerevisiae, G5011-25MG, 20 mg/kg body weight) dis-
solved in Dulbecco’s Phosphate Buffered Saline (PBS).
The control mice received a respective volume of PBS.
The animals were terminated 3 h, 1 day or 2 days after
injections. For the preconditioning design, mice were
challenged on day 0 with PBS, 1 mg/kg LPS or 20 mg/kg
BG. On day 2, 7 or 14, the mice received a secondary in-
jection of PBS or 1 mg/kg LPS and were sacrificed 3 h
later. The mice were put under deep anesthesia and
blood was collected in MiniCollect serum separator
tubes (Greiner Bio-one, 450472). Next, mice were per-
fused with saline, brains were isolated and divided into
two hemispheres, used for microglia isolation and im-
munohistochemistry respectively.
Microglia isolation
Microglia were isolated from adult mouse brain using
standardized procedures as described before [35]. Briefly,
the brain hemispheres were mechanically dissociated
using a tissue homogenizer. The homogenized brain
samples were passed through a 70 μM cell strainer to
obtain single cell suspensions which were centrifuged at
220 g for 10 min at 4 °C. The supernatants were re-
moved and the pellets were resuspended in 24% Percoll
(GE Healthcare, 17-0891-01) gradient buffer with 3 mL
PBS on top. Myelin was removed by centrifuging at 950
g for 20 min at 4 °C. The resulting cell pellets were incu-
bated with an antibody solution, containing Cd11b-PE
(eBioscience, 12-0112-82), Cd45-FITC (eBioscience, 11-
0451-85) and Ly6C-APC (Biolegend, 128015). Microglia
were isolated using fluorescence-activated cell sorting
(FACS) as DAPIneg Cd11bhigh Cd45int Ly6Cneg events.
The cells were collected and centrifuged at 600 g for 10
min. Subsequently, the pellets were lysed in RLT-Plus
buffer from RNeasy® Micro Kit (Qiagen, 74004) and
stored at -80 °C for RNA isolation.
RNA isolation and Quantitative RT-PCR (qPCR)
The microglia RNA was isolated using the RNeasy® Mi-
cro Kit following the manufacturer’s instructions. The
isolated RNA was mixed with 1 μL random primers (0.5
μg/μL, Invitrogen, 48190011) and water to 10 μL. Sam-
ples were incubated at 65°C for 15 min and kept on ice.
Thereafter, 8 U/μL M-MuLV reverse transcriptase
(Thermo Scientific, EP0442), 0.8 U/μL Ribolock RNase
inhibitor (Thermo Scientific, EO0382), 0.5 mM dNTP-
mix (Thermo Scientific, R0192) and reverse transcriptase
buffer were added and incubated on a thermal cycler at
42 °C for 1h, at 70 °C for 10 min and finally at 4 °C. The
resulting cDNA was used for qPCR reactions. The PCR
reaction mixture contained 5 μL diluted cDNA template
from microglia samples, 5.5 μL iTaq™ Universal SYBR®
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Green Supermix (Bio-Rad, 1725125), 0.3 μL H2O and
0.2 μL 10 μM primer mix. Each sample was run with 2
to 3 technical replicates. Quantitative PCR reactions
were performed using the QuantStudio 7 Real-Time
PCR system (Thermo Scientific) and Gapdh or Hrpt1
was used as a reference gene. Primer sequences are pro-
vided in Additional file 1.
Cytokine antibody array
A commercial cytokine antibody array (RayBiotech,
AAM-CYT-3-8) was used to determine cytokine levels
in the serum. Sera from replicates per experimental
group were pooled together and diluted 4x. The arrays
were blocked using blocking buffer for 30 min at room
temperature (RT). After aspirating the buffer, the diluted
samples were added to the arrays and left to incubate
overnight at 4°C. The arrays were washed and incubated
with a biotinylated antibody cocktail for 2 h at RT. After
a second wash, HRP-streptavidin was added to the ar-
rays, followed by incubation for another 2 h at RT. After
a final wash, excess wash buffer on the membranes was
removed and detection buffer was added. The cytokine
images were taken using the Odyssey Fc imaging system
(LI-COR biosciences). Densitometric analysis of the im-
munoreactivity of each cytokine was performed using
image analysis software (QuantityOne). To avoid the
background noise, cytokines or chemokines of which
density level is below the negative control on any mem-
branes were excluded.
Immunohistochemistry
Brain hemispheres were fixed for 48 h in 4% paraformal-
dehyde (PFA) at 4°C. After dehydration in 30% sucrose,
the brain samples were embedded with O.C.T. com-
pound (Sakura Finetek, 4583) and stored at -80°C. Six-
teen μm thick brain sections were prepared with the
cryostat. The sections were dried in the desiccator for 30
min, followed by fixation with 4% PFA in PBS for 20
min. After washing thrice with 1x PBS (identical for all
subsequent washing steps), antigen retrieval (AR) was
performed using 10 mM sodium citrate, pH 6.0. After
washing, the sections were incubated in PBS with 1%
hydrogen peroxide (H2O2) to block endogenous peroxid-
ase. The sections were washed and blocked using 5%
normal donkey serum (NDS; Jackson Immuno Research)
in PBS+ (PBS with 0.3% Triton X-100). The sections
were incubated with the primary rabbit-α-ionized
calcium-binding adapter molecule 1 (Iba1) antibody (1:
1000; Wako, 019-19741) overnight at 4 °C. The follow-
ing day, the slides were washed and incubated with the
biotinylated secondary donkey-α-rabbit IgG antibody (1:
400; Jackson Immuno Research, 711-065-152) for 1 h.
After washing, the sections were incubated with ABC so-
lution (VECTASTAIN® ABC Kit, Vector Laboratories,
PK-6100) for 30 min. The sections were washed, stained
using 0.04% 3,3’-Diaminobenzidine (DAB) and 0.01%
H2O2 for 8 min and subsequently dehydrated using in-
creasing ethanol concentrations. The slides were left to
air dry for 30 min, mounted with coverslips using DePex
(Serva) and stored at RT.
Morphometric analysis of microglia
All the slides were scanned with the NanoZoomer Digital
Pathology system (Hamamatsu Photonics, K.K., Japan)
with 40X objective resulting in NDPI files. A pipeline was
developed to computationally analyze a panel of 23 mor-
phological features in microglia (Van Weering et al., in
prep.). Briefly, single-cell images of Iba1-positive cells were
first extracted from the whole slide scans. Next, the
single-cell images were pre-processed to cell silhouette
images by semi-automated thresholding. Subsequently,
the cell silhouettes were converted to cell skeleton images
by repeated thinning and pruning of the branch areas. In
the cell skeleton, branch endings (end nodes), branch
crossings (junctions) and all branchpoints emanating from
the cell soma (start nodes) were tagged respectively to
allow node quantification. Both cell silhouette and cell
skeleton images served as input for fully automated mor-
phometric analysis. The outputs of the pipeline included
Sholl analysis [36], and 23 morphometric features per cell.
A specified list of morphometric features and a detailed
description of the pipeline were described elsewhere (Van
Weering et al., in prep.).
Clustering of microglia based on morphometric features
To identify groups of microglia with similar morphology,
a non-supervised clustering approach was applied as de-
scribed before (Van Weering et al., in prep.). In brief,
after normalization and scaling of all morphometric fea-
tures, a principal component analysis (PCA) was applied
to reduce dimensionality and redundancy in the dataset.
Subsequently, hierarchical clustering based on Ward’s
method was performed on the top-contributing principal
components (PCs) with an eigenvalue > 1. For example,
for the acute design in the cortex region, the top five
PCs (PC1-5) with an eigenvalue > 1 were retained for
clustering (Additional file 2a), resulting in 6 clusters of
microglia with distinct morphological properties (Add-
itional file 2b). The morphometric properties of each
cluster are depicted in Additional file 2c.
Statistical analysis
Statistical comparisons were performed by one-way
ANOVA, followed by Bonferroni multiple comparison.
For the morphometric data, type II Wald chi-square test
for linear mixed models was used to compare experi-
mental groups. For all statistical tests, the significance
level was set to p < 0.05.
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Results
BG activates microglia without inducing significant
cytokine expression in vivo
First, to determine whether BG could activate microglia,
its effect on primary microglia and a microglia BV-2 cell
line carrying a NF-κB luciferase reporter gene was ana-
lyzed. We first investigated the time course of LPS- and
BG-induced NF-κB activation by measuring luciferase
activity. Stimulation of BV-2 luciferase cells with 100 ng/
mL LPS resulted in significantly increased luciferase ac-
tivity after 30 min which peaked around 4 h (Additional
file 3a). 10 μg/mL BG activated NF-κB signaling within 2
h and peaked around 6 h after stimulation (Additional
file 3a). In addition, NF-κB luciferase reporter activity
was induced by LPS or BG in a concentration-
dependent manner (Additional file 3b). Next, the effect
of BG on primary microglia cells was determined. Pri-
mary microglia were stimulated with LPS or BG, and
after 3 hr, mRNA levels were quantified using RT-qPCR.
Both LPS (100 ng/mL) and BG (10 μg/mL) significantly
induced Tnf, Il6, Il1β, Ccl3 and Csf1 expression in pri-
mary microglia (Additional file 3c).
To investigate the effects of a systemic BG challenge
on microglia in vivo, mice received an i.p. injection with
20 mg/kg BG dissolved in PBS. Mice injected with LPS
(1 mg/kg) and PBS were included as positive and nega-
tive controls, respectively. Mice were terminated 3 h, 1
and 2 days after respective injections (Fig. 1a). Microglia
were FACS-isolated from the brains, and cytokine gene
expression levels were determined by qPCR. At 3 h after
an LPS injection, microglia exhibited a classical inflam-
matory response, showing significantly increased expres-
sion of Tnf, Il6, Il1β, Ccl2, Ccl3 and Csf1 compared to
PBS controls (Fig. 1b). At 2 days after LPS injection, the
expression levels of these cytokine genes were back at
baseline (Fig. 1b). Although we observed microglia acti-
vation in response to BG in cell culture, in vivo adminis-
tration did not induce a significant expression of Tnf,
Il6, Il1β, Ccl2, Ccl3 or Csf1 in microglia at any timepoint
investigated, an observation in accordance with previous
in vitro work [29] (Fig. 1b). However, at 3 h after BG in-
jection, Dectin-1 gene expression levels were significantly
decreased in microglia compared to PBS controls (Fig.
1c), indicating systemic BG can activate microglia. Like
BG, LPS downregulated Dectin-1 gene expression at 3 h
and 1 day after injection (Fig. 1c). Tlr4 expression levels
were not significantly altered by BG or LPS.
BG does not induce morphological changes in cortical
and hippocampal microglia
Next, microglia morphological changes in response to
LPS and BG injections were investigated in the cortex by
Iba1 immunostaining. At 3 h after LPS injection, no ob-
vious morphological changes in cortical microglia were
detected (Fig. 2a). At 1 and 2 days after LPS injection,
pronounced morphological changes were observed,
characterized by increased soma size and retracted pro-
cesses compared to PBS controls (Fig. 2a). For BG, no
obvious changes were observed at 3 h, 1 and 2 days after
injection (Fig. 2a). To compare the degree of microglia
ramifications across groups, we performed Sholl ana-
lyses. At 2 days after LPS injection, an increased number
of intersections in the range of 5-20 μm distance from
the soma was observed (Fig. 2b). In contrast, BG did not
affect microglia ramification (Fig. 2b). Summarizing,
these results indicate that an i.p. LPS challenge signifi-
cantly affected cortical microglia morphology, and that
an i.p. BG injection had limited effects. To quantify mor-
phological changes in microglia, we used a self-
developed pipeline to perform morphometric analysis on
microglia, randomly selected in the cortex across differ-
ent groups. Additional file 4 contains detailed morpho-
metric information of all selected cells and statistical
comparisons between different experimental groups in
cortical microglia for all features measured. At 3 h after
LPS injection, only cell circularity values were signifi-
cantly increased compared to PBS controls (Fig. 2c and
Additional file 4). At 2 days after LPS injection, more
morphological features, such as soma area, the number
of end nodes and cell solidity were significantly changed
compared to PBS controls (Fig. 2c and Additional file 4).
In contrast, the effect of BG on morphological features
of microglia was very limited (Fig. 2c and Additional file
4).
Next, we performed principal component analysis
(PCA) to reduce the dimensionality of the cortex micro-
glia morphometric dataset. Extensive overlap between
microglia from BG-treated groups and PBS-treated
group was observed (Fig. 2d), indicating similar micro-
glia morphologies. In contrast, some microglia in the
LPS-1d and LPS-2d groups segregated in the PCA plot
(Fig. 2d), indicating morphological differences. To iden-
tify microglia subsets with similar morphologies, we per-
formed a hierarchical clustering on the main
contributing principal components, as described in
methods section (Additional file 2), resulting in 6 micro-
glia clusters (I-VI) with distinct morphological properties
(Fig. 2e). The representative cell silhouettes for each
cluster are depicted in Fig. 2f. Cells in cluster I and II
were characterized by relatively long branch lengths and
small soma sizes (Fig. 2f). In contrast, cells in cluster VI
had a relatively large soma size and short branch length
(Fig. 2f) and were exclusively derived LPS-treated groups
(Fig. 2e). Next, we analyzed the relative distribution of
these distinct microglia clusters over the respective
treatment groups. In PBS-injected mice, microglia clus-
ters I-V were present, indicating microglia were mor-
phologically heterogeneous even under homeostatic
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conditions (Fig. 2g). At 3 h after LPS injection, microglia
cluster distributions were only mildly affected compared
to control conditions (Fig. 2g). However, at 1 and 2 days
after LPS injection, the relative proportion of cluster I
microglia increased, cluster II microglia were consider-
ably reduced and cluster VI microglia appeared (Fig. 2g).
In contrast, at 3h, 1 and 2 days after BG injection, the
distribution of the different microglia clusters was only
slightly different compared to control conditions (Fig.
2d,g). These results indicated that LPS induced a subset
of microglia with a reactive morphology in cortex,
whereas this subset of microglia was not detected in re-
sponse to BG.
Given the regional heterogeneity of microglia [37, 38],
microglia cells in the hippocampus were also randomly se-
lected and analyzed. Additional file 4 provides detailed
morphometric information of all selected cells and statis-
tical comparisons between different experimental groups
in the hippocampus for all features measured. Similarly,
BG induced only mild morphological changes in hippo-
campal microglia, while an LPS challenge, like was ob-
served in the cortex, resulted in a subset of microglia with
a morphologically reactive profile (Additional file 4 and 5).
In summary, these results indicate that where a systemic
LPS challenge resulted in extensive morphological
changes in microglia, a BG challenge did not result in al-
tered cortical and hippocampal microglia morphology.
Systemic administration of BG induces immune training
in microglia
To determine if BG induced immune memory in micro-
glia in vivo, we first challenged mice with BG or LPS,
Fig. 1. BG activates microglia without inducing significant cytokine gene expression in vivo. a Acute stimulation study design. Mice received a
single challenge of PBS, LPS (1 mg/kg) or BG (20 mg/kg) by i.p. injection. After 3 h, 1 day and 2 days, animals were terminated. b Microglia were
FACS-isolated and gene expression levels of Tnf, Il6, Il1β, Ccl2, Ccl3 and Csf1 were detected by qPCR and normalized to Gapdh gene expression
levels (n = 4 mice). c Expression levels of BG receptor gene Dectin-1 and LPS receptor gene Tlr4 were determined by qPCR and normalized to
Gapdh gene expression levels (n = 4 mice). Statistical significance was determined with a one-way ANOVA followed a Bonferroni correction for
multiple comparisons. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
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and after 2 days, we challenged the mice with LPS (Fig.
3a). For controls, mice were injected with PBS and after
2 days challenged with PBS of LPS. BG preconditioning
resulted in an increased transcriptional response to LPS
(Fig. 3b), indicating BG induced immune training of
microglia. Interestingly, with a 2-day interval between
the first and second challenge, LPS preconditioning also
induced immune training in microglia (Fig. 3b, LPS-2d-
LPS vs. PBS-2d-LPS group). In line with these findings,
it was shown that LPS preconditioning induced immune
training in microglia 1 day after the first challenge [28].
Nevertheless, LPS and BG trained microglia in different
Fig. 2. BG does not induce morphological changes in cortical microglia. a Representative images of Iba1-staining in the cortex across groups
(scale bar: 50 μm). b Violin plots of representative morphometric parameters for cortical microglia across experimental groups. Violin plots
represent the kernel densities for each group. Upper, middle and lower hinges of the boxplots represent the first, second (median) and third
quantiles, respectively. Whiskers extend to the minimum and maximum value still within the 1.5 x the interquartile range of the first and third
quantiles, respectively. Black dots represent outliers. The significance was determined by Wald chi-square test for linear mixed models. *, p < 0.05;
**, p < 0.01; ***, p < 0.001. c Sholl analysis of cortical microglia at 3 h, 1 day and 2 days after LPS or BG injection. PBS-injected mice microglia
served as the controls. The vertical lines represent +/- standard deviations. d PCA plot depicts all individual cells selected in cortex on principal
component plane. The x and y axes represent the first and second principal components (PC1 and PC2), respectively. e Hierarchical clustering on
principal components resulted in 6 cell clusters (I-VI). The dashed line indicates the cut off for 6 clusters. f Representative cells from each cluster
are shown. g Cluster distribution analysis of cortical microglia at 3 h, 1 day and 2 days after LPS or BG injection. Animals with PBS injection were
used as control. The number of microglia selected in the different groups: PBS: 80 cells; LPS-3h: 67 cells; LPS-1d: 63 cells; LPS-2d: 75 cells; BG-3h:
90 cells; BG-1d: 84 cells; BG-2d: 80 cells (n = 3 mice for each experimental group).
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ways: In terms of Tnf, Il-6 and Ccl3 expression, only BG
preconditioning significantly trained microglia (Fig. 3b);
but for Il-1β expression, only LPS could significantly
train microglia (Fig. 3b); for Ccl2 and Csf1 expression,
both LPS and BG could significantly train microglia (Fig.
3b). Since microglia cytokines gene expression levels
were back at baseline, 2 days after the first injection (Fig.
1b,c), the observed enhanced responsiveness to a second
LPS challenge was not due to a cumulative increase in
gene expression levels as a result of the first stimulation.
Taken together, LPS-and BG-induced immune training
of microglia was detected in vivo, 2 days after the pre-
conditioning stimulus.
Microglia gene expression levels of the BG and LPS re-
ceptors, Dectin-1 and Tlr4, respectively, were deter-
mined. Acute LPS stimulation resulted in near-
significant downregulation of Tlr4 and Dectin-1 expres-
sion in microglia (Fig. 3c, PBS-2d-LPS vs. PBS-2d-PBS
group). However, after LPS and BG preconditioning, a
second LPS injection did not result in reduced Dectin-1
expression (Fig. 3c, LPS-2d-LPS and BG-2d-LPS vs.
PBS-2d-LPS group), suggesting preconditioning damp-
ened the transcriptional response of Dectin-1 to an LPS
challenge. For Tlr4 expression, BG preconditioning did
not alter its expression in response an LPS challenge,
where LPS preconditioning seemed to further reduce
Tlr4 expression in response to LPS (Fig. 3c).
Next, we analyzed the persistence of BG induced im-
mune memory. We first challenged mice with 20 mg/kg
BG, and after 2, 7 or 14 days, we challenged the mice
with 1 mg/kg LPS (Additional file 6a). For the control
groups, mice were first challenged with PBS, and at 7
Fig. 3. BG induces immune training in microglia 2 days after injection. a Diagram of preconditioning experimental design with 2-day interval.
Mice were first challenged with PBS, LPS (1 mg/kg) or BG (20 mg/kg) by i.p. injection on day 0. On day 2, all the mice received a second
stimulation of PBS or LPS (1 mg/kg). Animals were terminated 3 h after the second injection. b Microglia were isolated and gene expression
levels of Tnf, Il1β, Ccl2, Ccl3, Il6 and Csf1 were determined using qPCR and normalized to Gapdh gene expression levels (n = 4 mice). c Gene
expression levels of Dectin-1 and Tlr4 were determined by qPCR and normalized to Gapdh gene expression levels (n = 4 mice). The significance
was calculated by one-way ANOVA followed a Bonferroni correction for multiple comparisons. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
Heng et al. Journal of Neuroinflammation           (2021) 18:57 Page 8 of 15
days after the first injection, mice were re-challenged
with PBS or 1 mg/kg LPS (Additional file 6a). We also
included an LPS preconditioning group, as we previously
reported that LPS preconditioning resulted in immune
tolerance in microglia after 7 days [27]. Three hours
after the second injection, mice were terminated (Add-
itional file 6a), microglia were isolated and qPCRs were
performed. In accordance with our previous findings
[27], LPS preconditioning induced immune tolerance in
microglia 7 days later, reflected by reduced expression of
Tnf, Il6, Il1β, Ccl2, Ccl3 and Csf1 to a subsequent LPS
stimulation (Additional file 6b, LPS-7d-LPS vs. PBS-7d-
LPS group). Preconditioning by i.p. BG injection resulted
in enhanced expression of Tnf, Il6, Il-1β and Csf1 2 days
later (Additional file 6b, BG-2d-LPS vs. PBS-7d-LPS
group). However, at 7 or 14 days after the first BG chal-
lenge, this BG immune training phenotype was no lon-
ger detected (Additional file 6b).
LPS- and BG-preconditioned mice microglia display an
enhanced reactive morphology in response to a second
LPS injection
Next, we performed morphometric analysis of Iba1-
stained microglia in the cortex of LPS- and BG-
preconditioned mice that received a second LPS injec-
tion. In the cortex, at 3h after a second LPS injection,
we observed prominent morphological changes in
microglia in LPS preconditioned mice (LPS-2d-LPS
group) compared to controls (PBS-2d-PBS group) or
mice that only received the second LPS challenge (PBS-
2d-LPS group) (Fig. 4a). In BG-preconditioned mice,
some microglia also exhibited pronounced morpho-
logical changes in response to a second LPS injection
(Fig. 4a), but less robust compared to LPS-
preconditioned microglia. Sholl analysis showed that
LPS-2d-LPS group microglia had more intersections at
~5 μm to ~15 μm distance from the soma and a shorter
maximum branch radius compared to PBS-2d-LPS
group (Fig. 4b). For the microglia in the BG-2d-LPS
group, the branching profile was quite similar to the
PBS-2d-LPS group (Fig. 4b). Soma area, the number of
start nodes, cell solidity and convex area were all signifi-
cantly altered in LPS-2d-LPS microglia (Fig. 4c). Detailed
morphometric information of all selected cells and stat-
istical comparisons between different experimental
groups in cortex for all features measured are provided
in Additional file 7. These results indicate that both
LPS- and BG-preconditioning resulted in increased mor-
phological changes in microglia to a second LPS chal-
lenge, and these changes were most pronounced in LPS-
preconditioned mice.
PCA was performed on the cortical microglia morpho-
metric dataset. An extensive overlap was observed be-
tween microglia from PBS-2d-LPS group and PBS-2d-
PBS group (Fig. 4d), indicating similar morphologies. In
contrast, some BG- but especially LPS-preconditioned
microglia were more segregated from PBS-2d-PBS
microglia (Fig. 4d). Next, we performed hierarchical
clustering on the main contributing principal compo-
nents, resulting in 6 microglia clusters (I-VI) with dis-
tinct morphological properties (Fig. 4e). Cell silhouettes
representative for each cluster are depicted (Fig. 4f).
Cells in cluster I and II had a relatively long branch
length and small soma size; cells in cluster IV, V and VI
showed a typical activated morphology with a relatively
large soma size and short branch length (Fig. 4f). Next,
we analyzed the relative distribution of these distinct
microglia clusters over the respective treatment groups.
Similar to our previous finding (Fig. 2g), 3 h after an
acute LPS stimulation, microglia cluster distribution was
only mildly affected compared to control conditions
(Fig. 4g, PBS-2d-LPS vs. PBS-2d-PBS group). However,
in LPS preconditioned mice, the percentages of clusters
IV, V and VI microglia considerably increased (Fig. 4g).
In the BG-2d-LPS group, an increase in cluster IV, V
and VI microglia was observed compared to control
(PBS-2d-PBS) and acute LPS stimulated mice (PBS-2d-
LPS) but much less than was observed in the LPS-2d-
LPS group (Fig. 4g). These results indicate that com-
pared to PBS-preconditioned mice microglia, a subset of
microglia acquired a reactive morphology after a second
LPS injection in LPS- and BG-preconditioned mice.
Similar results were also observed in the hippocampus
region (Additional file 8), demonstrating that these mor-
phological changes were not restricted to the cortex. Add-
itional file 7 provides detailed morphometric information
of all selected cells and statistical comparisons between
different experimental groups in the hippocampus. In
summary, LPS- and BG-preconditioned mice microglia
display an increased reactive morphology in response to a
second LPS injection in cortex and hippocampus.
Systemic administration of BG and LPS induces immune
tolerance in the periphery
In this study, microglia innate immune memory was in-
duced by systemic administration of LPS or BG. How-
ever, previous studies have shown that systemic
challenges can also alter the epigenetic signature of per-
ipheral immune cells and their response to subsequent
stimuli [9–11]. To determine whether the peripheral re-
sponse to LPS is affected by preconditioning, serum
cytokine concentrations of BG- and LPS-preconditioned
mice were determined 3 h after the second LPS chal-
lenge by means of a cytokine array (Fig. 5a). Similar to
previous findings [28], LPS induced peripheral immune
tolerance 2 days after the first LPS injection, as evi-
denced by decreased serum concentrations of IL-1β,
IFN-γ and IL-12 p70 when compared to cytokine serum
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concentrations of mice exposed to a single LPS injection
(Fig. 5b, LPS-2d-LPS vs. PBS-2d-LPS group). Interest-
ingly, in the BG-2d-LPS group, serum concentrations of
pro-inflammatory cytokines such as IL-1β, IFN-γ, IL-12
p70 and IL-6 were reduced when compared to PBS-2d-
LPS mice (Fig. 5b), suggesting BG also induced
Fig. 4. LPS- and BG-preconditioned mice microglia display an exaggerated reactive morphotype in response to a second LPS injection in cortex.
a Representative images of Iba1-staining in the cortex across different groups (scale bar: 50 μm). b Violin plots of representative morphometric
parameters for cortical microglia across experimental groups. The significance was determined by Wald chi-square test for linear mixed models. *,
p < 0.05; **, p < 0.01; ***, p < 0.001. c Sholl analysis of cortical microglia across groups. The vertical lines represent +/- standard deviations. d PCA
plot depicts all individual cells selected in cortex on principal component plane. The x and y axes represent the first and second principal
components (PC1 and PC2), respectively. e Hierarchical clustering on principal components resulted in 6 cell clusters (I-VI). The dashed line
indicates the cut off for 6 clusters. f Representative cells from each cluster are shown. g Cluster distribution analysis of LPS- and BG-
preconditioned mice microglia 3 h after second LPS challenge in cortex. Microglia from naïve mice with two PBS injections (PBS-2d-PBS group)
and mice that only received one LPS challenge for 3 h (PBS-2d-LPS group) were included as controls. The number of microglia selected in the
different groups: PBS-2d-PBS: 228 cells; PBS-2d-LPS: 210 cells; LPS-2d-LPS: 220 cells; BG-2d-LPS: 208 cells (n= 4 mice for each experimental group).
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peripheral immune tolerance. These results show that
with an interval of 2 days between the first and second
challenge, LPS and BG preconditioning both induced
immune tolerance in the periphery, suggesting that the
immune training observed in microglia is most likely
driven by microglia-intrinsic changes, possibly by epi-
genetic alterations as reported previously [28]. However,
a contribution of peripheral immune cells cannot be
ruled out as some peripheral cytokines or chemokines
like IL-5, CXCL4 and CXCL9 also showed an enhanced
response to LPS, 2 days after a BG challenge (Fig. 5b).
Discussion
Microglia, the resident macrophages of the CNS, play an
important role in brain development and homeostasis.
Infections or any other disturbances to the homeostasis
of the brain induce immediate activation of microglia,
which is accompanied by the secretion of cytokines, pro-
duction of ROS, altered phagocytic activities and mor-
phological changes [39]. The discovery of innate
immune memory in microglia has revealed an important
and previously unrecognized CNS immune property,
showing that, besides the local environment, previous in-
flammatory experiences can affect the microglial re-
sponse to a sequential challenge [26]. LPS and BG are
two commonly used immune modulators in monocytes
and macrophages [3, 5, 19]. Several studies have con-
firmed that LPS preconditioning can induce immune
training and tolerance in microglia in vivo and in vitro
[27, 28, 40]. Compared to LPS, the effects of BG on
Fig. 5. Peripheral immune tolerance in LPS- and BG-preconditioned mice. Mice were first challenged with PBS, LPS (1 mg/kg) or BG (20 mg/kg)
by i.p. injection. Two days later, the mice received a second stimulation with PBS or LPS (1 mg/kg). Animals were terminated 3 h after the second
injection. Sera of mice in the same experimental group were pooled (n = 4 for each group). Cytokine levels were measured with a cytokine array
(a). Densitometric analysis of the immunoreactivity of each cytokine or chemokine was performed. After filtering, a heatmap was generated
based on optical density levels of cytokines and chemokines (b).
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microglia innate immune memory are poorly under-
stood, especially in vivo. Notably, BG induced immune
training in microglia, as mice preconditioned with BG
displayed an enhanced responsiveness to a subsequent
LPS exposure, as evidenced by the increased cytokine
gene expression and morphological changes in
microglia.
In our previous study, we reported that systemically
administered LPS induced microglia immune tolerance 7
days later in vivo [27], which is also confirmed in this
study. In addition, we previously showed that LPS-
induced immune tolerance in microglia could last at
least 32 weeks after the first challenge [27]. However,
with the same dose of LPS (1 mg/kg), we observed im-
mune training instead of immune tolerance 2 days after
the first injection. With the dose of BG used in this
study, we only observed immune training in microglia 2
days after preconditioning, and this training phenotype
was no longer detectable at 7 and 14 days after the first
BG challenge. These results indicate that the time inter-
val between the first and second challenge is crucial to
unravel microglia innate immune memory in vivo. In
addition, different LPS treatment paradigms were re-
ported to induce different microglia innate immune
memories in microglia [28]. A single i.p. LPS injection
(0.5 mg/kg) caused an immune training response 24 h
after, while 4 daily, consecutive LPS injections (with the
same dose) induced immune tolerance in microglia [28].
More systemic investigations are needed to delineate
how different intervals between challenges, the pathogen
type, its dose and the number of exposures affect the
microglia innate memory response.
Wendeln et al. showed that 6 months after a desensi-
tizing stimulation, tolerized microglia showed significant
loss of H3K4me1 on enhancers of genes related to PI3K-
Akt signaling pathway [28], suggesting PI3K-Akt signal-
ing is suppressed during microglia immune tolerance. In
a recent in vitro study, Lajqi et al. showed that, in re-
sponse to a second LPS challenge, TLR4, MyD88 and
phospho-p65 were more responsive in trained microglia
induced by an ultralow LPS dose (1 fg/mL) of LPS com-
pared to naïve microglia, and that immune training is
mediated by the PI3K-Akt signalling pathway [40]. Based
on these results, it is possible that the first BG injection
also induced immune training in microglia via the PI3K-
Akt and NF-κB pathways.
Our cytokine array results show that with an interval
of 2 days between the first and second challenge, LPS
and BG preconditioning both induced peripheral im-
mune tolerance. In a previous study [24], BG precondi-
tioning was shown to induce immune training in the
periphery. This difference might have several causes.
First, the time interval between two challenges was dif-
ferent (2 days in this study, 4 days in the previous study).
Second, in the previous study, BG from C. albicans was
used, while we used BG from S. cerevisiae. And it is
known that the immune stimulatory effects of BGs are
linked to their structural complexity which is highly re-
lated to the BG source [18, 21]. Third, it has been shown
in vitro that the degree and type of innate immune re-
sponse in monocytes also depends on the concentration
of the ligand the cells are exposed to [41]. In our study,
we used a slightly lower dose of BG (20 mg/kg in this
study, 1 mg/animal in the previous study). Recently,
Wendeln et al. showed that one individual cytokine,
TNF-α, applied peripherally also could induce immune
memory in the brain [28]. Peripheral cytokine profiles
need to be further characterized by multiplex cytokine
assays after a first challenge. Then, the potential cytokine
or chemokine induced by the first challenge could be ap-
plied individually or blocked by neutralizing antibodies
in the periphery, to study the influence of individual cy-
tokines or chemokines on microglia innate immune
memory. And conversely, it would also be a useful ex-
periment to employ mice lacking receptor such as TLR4
or for a specific cytokine conditionally only in microglia.
These experiments would improve our knowledge of the
crosstalk between the periphery and the brain in micro-
glia innate immune memory. It is difficult to separate
microglia immune training from the peripheral response
in vivo and to identify the responsible peripheral cell
types. It is known that a peripheral LPS challenge can
epigenetically alter microglia, and change their response
to a second challenge. However, also the peripheral re-
sponse to a second challenge can be altered by a precon-
ditioning stimulus. As a consequence, the response of
microglia to a challenge in preconditioned mice is prob-
ably the result of an altered microglia response (due to
intrinsic i.e. epigenetic) changes in combination with an
altered peripheral response.
As long-lived tissue macrophages in the CNS, micro-
glia innate immune memory induced by a previous
stimulus might have long term functional impacts. We
previously showed that LPS-induced immune tolerance
in microglia could at least last for 32 weeks [27]. Wen-
deln et al. showed that microglia are transcriptionally
and epigenetically altered even 6 months after LPS chal-
lenges [28]. LPS-induced immune training exacerbated
pathology and LPS-induced immune tolerance alleviated
cerebral β-amyloidosis [28]. This beneficial effect of im-
mune tolerance was also observed in a stroke mouse
model [28]. Recently, in primary microglia, chronic ex-
posure (twice a 24 h exposure with an interval of 3-5
days) to Aβ induced immune tolerance and metabolic
defects. This defect was characterized by reduced gly-
colysis and oxidative phosphorylation compared to
microglia exposed only to Aβ once [42]. In addition,
metabolic boosting with IFN-γ could restore
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immunological function of microglia [42]. Similarly, in
monocytes, β-glucan partially reversed LPS-induced im-
mune tolerance through epigenetic regulation [5]. In this
study, we showed that β-glucan could induce immune
training in microglia. It would be interesting to investi-
gate whether β-glucan or other immune modifiers could
reverse the immune state of microglia in disease condi-
tions. Thus, modulating innate immune memory in
microglia is a promising target to develop treatment for
microglia-associated diseases.
Conclusion
Our results show that BG activated microglia without in-
ducing significant cytokine expression. BG- and LPS-
preconditioning both induced immune training in
microglia two days after the first challenge. However,
with an interval of 7 days between the first and second
challenge, LPS-preconditioning induced immune toler-
ance in microglia where BG-induced immune training
was no longer detected.
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Additional file 1. Information on qPCR primers.
Additional file 2. Categorization of microglia with similar shape and
size by means of hierarchical clustering on principal components (PCs).
Here we used the acute design cortex dataset as an example. To reduce
the dimensionality of the dataset, a PCA was performed. a) Table depicts
the eigenvalues, the variance retained and the cumulative variance for
the first 10 PCs. PCs with an eigenvalue > 1 (here, PC1-PC5) were retained
for hierarchical clustering. b) Hierarchical clustering on the first 5 PCs re-
sulted in 6 distinct morphological clusters (I-VI). c) Heatmap represents
the z-scores for all morphometric features for microglia clusters I-VI.
Additional file 3 BG and LPS activate NF-κB signaling in a BV-2 cell line
and induce cytokine gene expression in primary microglia. a) A BV-2 cell
line carrying a NF-κB -luciferase reporter gene was stimulated by LPS (100
ng/mL) or BG (10 μg/ml) for the times indicated (ranging from 15 min to
24 h). Luciferase activity was determined and normalized to PBS treated
cells. b) BV-2 cells carrying a NF-κB-luciferase reporter gene were stimu-
lated for 4 h with different concentrations of LPS or BG. c) Primary micro-
glia were stimulated by LPS (100 ng/mL) or BG (10 μg/ml). After 3 h, cells
were washed by PBS and RNA was isolated. Expression levels of Tnf, Il6,
Il1β, Ccl3 and Csf1 were determined by qPCR and normalized to Hprt1
gene expression levels. Statistical significance was determined with a
one-way ANOVA followed a Bonferroni correction for multiple compari-
sons. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
Additional file 4. Raw morphometric information for all cells analyzed
in acute design, cortex and hippocampus regions. Statistical comparisons
between experimental groups are also provided.
Additional file5 BG does not induce morphological changes in
hippocampal microglia. a) Representative images of Iba1-staining in the
hippocampus across groups (scale bar: 50 μm). b) Violin plots of represen-
tative morphometric parameters for cortical microglia across experimental
groups. The significance was determined by Wald chi-square test for lin-
ear mixed models. *, p < 0.05; **, p < 0.01; ***, p < 0.001. c) Sholl analysis
of hippocampal microglia at 3 h, 1 day and 2 days after LPS or BG injec-
tion. PBS-injected mice microglia served as the controls. The vertical lines
represent +/- standard deviations. d) PCA plot depicts all individual cells
selected in hippocampus on principal component plane. The x and y
axes represent the first and second principal components (PC1 and PC2),
respectively. e) Hierarchical clustering on principal components resulted
in 6 cell clusters (I-VI). The dashed line indicates the cut off for 6 clusters.
f) Representative cells from each cluster are shown. g) Cluster distribution
analysis of hippocampal microglia at 3 h, 1 day and 2 days after LPS or
BG injection. Animals with PBS injection were used as control. The num-
ber of microglia selected in the different groups: PBS: 42 cells; LPS-3h: 49
cells; LPS-1d: 51 cells; LPS-2d: 48 cells; BG-3h: 39 cells; BG-1d: 49 cells; BG-
2d: 51 cells (n = 3 mice for each experimental group).
Additional file 6 BG induces immune training in microglia in vivo 2
days after the first injection. a) Diagram of preconditioning experimental
design. Mice received first challenge of PBS, LPS (1 mg/kg) or BG (20 mg/
kg) by i.p. injection. After 2, 7 or 14 days, the same mice received second
challenge with PBS or LPS (1 mg/kg). Animals were terminated 3 h after
the second injection. b) Microglia were isolated and Tnf, Il6, Il-1β, Ccl2,
Ccl3 and Csf1 gene expression levels were detected by qPCR and
normalized to Hprt1 gene expression levels (n = 3 mice).
Additional file 7. Raw morphometric information for all cells analyzed
in preconditioning design, cortex and hippocampus regions. Statistical
comparisons between experimental groups are also provided.
Additional file 8. LPS- and BG-preconditioned mice microglia display an
exaggerated reactive morphotype in response to a second LPS injection
in hippocampus. a) Representative images of Iba1-staining in the
hippocampus across different groups (scale bar: 50 μm). b) Violin plots of
representative morphometric parameters for hippocampal microglia
across experimental groups. The significance was determined by Wald
chi-square test for linear mixed models. *, p < 0.05; **, p < 0.01; ***, p <
0.001. c) Sholl analysis of hippocampal microglia across groups. The
vertical lines represent +/- standard deviations. d) PCA plot depicts all
individual cells selected in hippocampus on principal component plane.
The x and y axes represent the first and second principal components
(PC1 and PC2), respectively. e) Hierarchical clustering on principal
components resulted in 6 cell clusters (I-VI). The dashed line indicates the
cut off for 6 clusters. f) Representative cells from each cluster are shown.
g) Cluster distribution analysis of LPS- and BG-preconditioned mice
microglia 3 h after second LPS challenge in hippocampus. Microglia from
naïve mice with two PBS injections (PBS-2d-PBS group) and mice that
only received one LPS challenge for 3 h (PBS-2d-LPS group) were
included as controls. The number of microglia selected in the different
groups: PBS-2d-PBS: 139 cells; PBS-2d-LPS: 138 cells; LPS-2d-LPS: 144 cells;
BG-2d-LPS: 137 cells (n= 4 mice for each experimental group).
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